% | $
Quotes you view appear here for quick access.

Threshold Pharmaceuticals Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • tredleon tredleon Dec 7, 2006 11:29 AM Flag

    Very encouraged after viewing Lazard presentation

    Actually, Baxter is more of a medical supply company - if you check their website, you'll see that they have very few products in the Oncology area, so Glufo was probably not a product that fit their strategic focus.

    THLD's investor presentation presents some nice pre-clinical data (i.e. in mice) supporting how it should work with Gemzar, so hopefully the PII results we will see this month will show consistent efficacy.

0.8561-0.1139(-11.74%)Aug 24 4:00 PMEDT